Design and prototyping exploration of an end effector for automated drug compounding
Proceedings of the Design Society · 2026-08 · 6 · 3287-3296
DOI: 10.1017/pds.2026.10686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the Design Society, online erschienen am 02.07.2026. Verfasst von Lorenzo Giunta und 1 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Chemotherapy (CTX) is essential for cancer treatment, yet its cytotoxic properties pose significant risks to clinicians. As cancer incidence rises, demand for safe and reliable CTX preparation methods intensifies; Automated Drug Compounding (ADC) promises to address these issues. Nonetheless, technical and operational barriers limit adoption. Foremost, the reliable manipulation of syringes by robotic end effectors remains a challenge. This paper examines limitations of current end effectors for ADC systems, identifies design requirements necessary, and proposes a novel design to address them.
Zitieren
APA
Giunta, L., & Dhokia, V. (2026). Design and prototyping exploration of an end effector for automated drug compounding. Proceedings of the Design Society, 6, 3287-3296. https://doi.org/10.1017/pds.2026.10686
Vancouver
Giunta L, Dhokia V. Design and prototyping exploration of an end effector for automated drug compounding. Proceedings of the Design Society. 2026;6:3287-3296. doi:10.1017/pds.2026.10686
BibTeX
@article{Giunta2026,
author = {Giunta, Lorenzo and Dhokia, Vimal},
title = {Design and prototyping exploration of an end effector for automated drug compounding},
journal = {Proceedings of the Design Society},
year = {2026},
volume = {6},
pages = {3287--3296},
doi = {10.1017/pds.2026.10686}
}
EUVIMED